Determination of ketamine and norketamine in plasma by micro-liquid chromatography-mass spectrometry.
A sensitive method of determination of ketamine and norketamine by micro-liquid chromatography/mass spectrometry was developed as part of a clinical trial in a pediatric population. Compounds were extracted from 100 microl plasma samples using solid-phase extraction on Oasis MCX cartridges. Separation was achieved on a C18 micro-column with a mobile phase composed of formic acid 0.1% and acetonitrile (90/10, v/v). Detection of ketamine, norketamine and their internal standard norketamine D4 was performed using selected ion monitoring at m/z 238.2, 224.2 and 228.2, respectively. Under these conditions, no loss of signal due to matrix effect was found and time of analysis did not exceed 10 min. Extracted calibration curves were linear from 5 to 500 ng/ml for each analyte, with correlation coefficients over 0.999. Intra- and inter-day validation studies showed mean recoveries between 98.1 and 101.7% and a relative standard deviation below 1.9%. Extraction recoveries ranged from 84.8 to 89.8% for both ketamine and norketamine. Limit of quantification was 4 ng/ml for each analyte.
Legrand
T
T
Laboratoire de Pharmacologie Pédiatrique et Pharmacogénétique, Assistance Publique-Hôpitaux de Paris, 48 boulevard Sérurier, 75019 Paris, France.
Roy
S
S
Monchaud
C
C
Grondin
C
C
Duval
M
M
Jacqz-Aigrain
E
E
D002648:Child; D002853:Chromatography, Liquid / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007649:Ketamine / Q000097:blood* / Q000737:chemistry; D013058:Mass Spectrometry / Q000379:methods*; D008832:Microchemistry / Q000379:methods; D015394:Molecular Structure; D016032:Randomized Controlled Trials as Topic; D012015:Reference Standards; D012680:Sensitivity and Specificity; D052616:Solid Phase Extraction / Q000379:methods; D013237:Stereoisomerism; D013997:Time Factors
D007649:Ketamine